Dual-target CAR-NK cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual-target CAR-NK cell therapy, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC [Phase 1, Phase 2]